Long Term Evaluation of Primary Congenital Glaucoma Management in Sohag University Hospital

Primary Congenital Glaucoma Clinical Trial

— PCG  

Official title:

Long Term Evaluation of Primary Congenital Glaucoma Management In Sohag University Hospital

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04949555
• Other study ID #: SohajuGF
• Status: Recruiting
• Start date: January 1, 2021
• Est. completion date: March 1, 2022

Study information

• Verified date: February 2022
• Source: Sohag University
• Contact: Ghada f mohamed, MBBCH
• Phone: 01004720821
• Email: ghada_fathy_post[@]med.sohag.edu.eg
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

evaluation of primary congenital glaucoma management in sohag university hospital

Description:

long term evaluation of primary congenital glaucoma management in sohag university hospital

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 150
• Est. completion date: March 1, 2022
• Est. primary completion date: March 1, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 3 Months and older

Eligibility

Inclusion Criteria:

• children operated more than 3 months

Exclusion Criteria:

• other types of operated pediatric glaucoma

Related Conditions & MeSH terms

• Glaucoma
• Primary Congenital Glaucoma

Intervention

Other:
• Primary congenital glaucoma evaluation
long term evaluation of primary congenital glaucoma management

Locations

Country	Name	City	State
Egypt	Ghada Fathy Mohamed	Sohag

Sponsors (1)

Lead Sponsor	Collaborator
Sohag University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	evaluation of patient with primary congenital glaucoma managed in sohag university hospital by surgical intervention,trabeculectomy and trabecultomy with mitomycin and ologen.follow up after management by measuring intra ocular pressure by Perkins.	retrospective study	3years